Journal of Atherosclerosis and Thrombosis

Papers
(The H4-Index of Journal of Atherosclerosis and Thrombosis is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Association between C-Reactive Protein Levels and Functional Disability in the General Older-Population: The Takashima Study218
Progress in Pathological Diagnosis after Kidney Transplantation: Current Trend and Future Perspective145
MAFLD and Small Dense LDL Cholesterol: A Mechanistic Link101
Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort92
Advances in Beyond Statin Lipid Therapies for ASCVD Risk Reduction77
Relationship between Kidney Function and Subclinical Atherosclerosis Progression Evaluated by Coronary Artery Calcification45
<i>JAK2</i> V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms40
<i>RNF213</i> p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden39
ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis37
Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial36
Impact of Changes in Lifestyle and Psychological Factors on the Incidence of Metabolic Syndrome after the Great East Japan Earthquake: Follow-up of the Fukushima Health Management Survey34
Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 202030
Atrial Cardiomyopathy Predicts the Functional Outcome and Mortality in Stroke Patients30
Growth Differentiation Factor-15 and Clinical Outcomes in Lower Extremity Artery Disease30
The Blockade of Delta-Like Ligand 1 Inhibits Atherosclerotic Lesion Formation and Attenuates Plaque Vulnerability30
The Role of Polygenic Risk Score in the General Population: Current Status and Future Prospects29
Atherosclerotic Diseases in Chronic Kidney Disease29
Cholesterol Efflux Capacity and Anti-Oxidative Activity of High-Density Lipoprotein in Chronic Kidney Disease28
Association of Visceral Fat Accumulation with Endothelial Glycocalyx Degradation in People with and without Type 2 Diabetes: A Retrospective Cross-sectional Study26
Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?26
Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial25
Non–high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke25
Thrombosis and Anticoagulation Strategies in Patients with COVID-19 Including Japanese Perspective24
Impact of Chronic Limb-Threatening Ischemia in Patients on Hemodialysis24
2.1500160694122